Aerosols

Respira Technologies, Inc. launches pharmaceutical focused commercial development platform to pursue API delivery partnerships with its proprietary RespiRx™ medical device platform

Retrieved on: 
Tuesday, June 2, 2020

WEST HOLLYWOOD, Calif., June 2, 2020 /PRNewswire/ -- Respira Technologies, Inc., a health-technology platform development company, announced today the launch of its pharmaceutical focused commercial development program for the RespiRxTM drug delivery device platform.

Key Points: 
  • WEST HOLLYWOOD, Calif., June 2, 2020 /PRNewswire/ -- Respira Technologies, Inc., a health-technology platform development company, announced today the launch of its pharmaceutical focused commercial development program for the RespiRxTM drug delivery device platform.
  • Respira Technologies' mission is to improve the standard of patient care and to improve public health outcomes by creating and commercializing cutting-edge drug delivery platforms.
  • Danek created the ResipRxTM to be the first truly patient focused & ultra-portable handheld Vibrating Mesh Nebulizer (VMN) for local and systemic treatment.
  • Respira has developed two proprietary platforms, an API agnostic drug delivery platform for water-soluble, thermosensitive drug compounds and a LOW-HEAT device platform for water-insoluble compounds.

Lafe's® Natural BodyCare: Save $1.00 with Ibotta

Retrieved on: 
Thursday, May 21, 2020

Ibotta is a free cash back reward and payment app that gives you real cash back on your Lafe's Deodorant purchase when you shop and pay through the app.

Key Points: 
  • Ibotta is a free cash back reward and payment app that gives you real cash back on your Lafe's Deodorant purchase when you shop and pay through the app.
  • On your phone, go to this link to get the offer: https://ibotta.com/rebates/505995/lafe-s-deodorant-stick?category=grocery
    Recognizing that cost often impacts the ability for a consumer to choose a toxic-free, natural deodorant over conventional, Lafe's Natural BodyCare's mission is focused on making natural and organic products affordable and accessible to everyone.
  • Lafe's $1.00 off promotion with Ibottais another way to further ease the cost of making the switch to a natural deodorant.
  • A safe and non-toxic deodorant shouldn't cost more and our $1.00 off promotion with Ibotta helps to support this mission,"Founder & Owner, Lafe Larson said.

Nebulizers' Demand Grows as Coronavirus Cases Rise, TBRC Report Suggests

Retrieved on: 
Tuesday, May 19, 2020

LONDON, May 19, 2020 /PRNewswire/ -- The current COVID-19 pandemic has resulted in a surge in demand for nebulizers.

Key Points: 
  • LONDON, May 19, 2020 /PRNewswire/ -- The current COVID-19 pandemic has resulted in a surge in demand for nebulizers.
  • There has been an increased use of albuterol inhalers in hospitals for COVID-19 and suspected COVID-19 patients to help with respiratory issues.
  • The market is expected to stabilize and reach $1.3 billion at a compound annual growth rate (CAGR) of 10.9% through 2023.
  • However, the development of technically advanced novel nebulizers is expected to reduce drug wastage and improve delivery efficacy.

InventHelp Inventor Develops More Secure Design for a Nebulizer (HTM-8564)

Retrieved on: 
Friday, May 15, 2020

The invention provides an improved nebulizer for individuals with asthma and other respiratory issues.

Key Points: 
  • The invention provides an improved nebulizer for individuals with asthma and other respiratory issues.
  • As a result, it prevents the fittings from popping apart when the nebulizer is turned on and it provides added peace of mind.
  • "My design prevents the tubing from popping off and scaring a patient during a nebulizer treatment."
  • The original design was submitted to the National sales office of InventHelp.

Polar Controller Mitigates Potential Spread of COVID-19 with New Indoor Airspace Management Technology

Retrieved on: 
Friday, May 15, 2020

JACKSONVILLE, Fla., May 15, 2020 /PRNewswire/ --Now that the country is beginning to come out of lockdown, indoor airspace management is becoming a concern in managing the spread of COVID-19 according to Polar Controller.

Key Points: 
  • JACKSONVILLE, Fla., May 15, 2020 /PRNewswire/ --Now that the country is beginning to come out of lockdown, indoor airspace management is becoming a concern in managing the spread of COVID-19 according to Polar Controller.
  • Unlike outdoor airspace, which scatters aerosol droplets over a larger area, indoor particulates hitch a ride on airspace currents, dispersing throughout business establishments.
  • Polar Controller is a remote Artificial Intelligence technology for cooling equipment that assists businesses with indoor airspace management, reducing electricity consumption, decreasing the carbon footprint associated with cooling and improving profitability.
  • Kaleb Zeringue, CEO/CTO for Polar Controller is a master HVAC technician, authority in the field and inventor of the Polar Controller system.

Lafe's® Natural BodyCare: Save More at Walmart

Retrieved on: 
Thursday, May 14, 2020

Recognizing that cost often impacts the ability for a consumer to choose a natural deodorant over conventional, Lafe's Natural BodyCare's mission is focused on making natural and organic products affordable and accessible to everyone.

Key Points: 
  • Recognizing that cost often impacts the ability for a consumer to choose a natural deodorant over conventional, Lafe's Natural BodyCare's mission is focused on making natural and organic products affordable and accessible to everyone.
  • Lafe's #24effect Campaign hopes to further ease the cost of making the switch to a natural, non-toxic deodorant, while also giving a fun way for people to win great prizes.
  • Lafe's is honored with several awards, including Better Nutrition's "Best of Natural Beauty Award", Natural Solutions "Beauty with a Conscience Award" and the prestigious The President's "E" Award for Exports.
  • Lafe's Deodorants are available at many retailers in North America: Walmart, select HEB, Shoprite, Stop & Shop, Giant Food, Fruitful Yield, Woodman's, The Vitamin Shoppe, and London Drugs.

Respiratory Devices Industry Outlook 2020-2024 - COVID-19 Pandemic Has Created a Favorable Impact on the Respiratory Market

Retrieved on: 
Thursday, May 14, 2020

The global respiratory devices market is forecasted to reach US$30.77 billion in 2024, growing at a CAGR of 5.93% for the period spanning 2020-2024.

Key Points: 
  • The global respiratory devices market is forecasted to reach US$30.77 billion in 2024, growing at a CAGR of 5.93% for the period spanning 2020-2024.
  • In 2020, the outbreak of the COVID-19 pandemic has created a favorable impact on the respiratory market as the demand for masks, respirators, protective clothing, and gloves has increased significantly not limited to the healthcare sector but also to other industries.
  • On the basis of product type, the global respiratory devices industry is broadly bifurcated into therapeutic (nebulizers, ventilators, Positive Air Pressure (PAP), humidifiers, etc.
  • The report provides a comprehensive analysis of the global respiratory devices market segmented on the basis of product types i.e.

Impact of COVID-19 on Global Nebulizer Market: Focus on Key Players Including Koninklijke Philips, Omron Corporation and Teleflex Incorporated

Retrieved on: 
Tuesday, May 12, 2020

The nebulizer market is expected to reach US$1.44 billion in 2024, recording a CAGR of 4.02%, during 2020-2024.

Key Points: 
  • The nebulizer market is expected to reach US$1.44 billion in 2024, recording a CAGR of 4.02%, during 2020-2024.
  • The global nebulizer market is fragmented into the jet nebulizer, mesh nebulizer and ultrasonic nebulizer.
  • The report provides a comprehensive analysis of the global nebulizer (Jet, Mesh & Ultrasonic) market.
  • The competitive landscape of the market, along with the company profiles of leading players (Koninklijke Philips, Becton, Dickson and Company, Omron Corporation, Agilent Technologies, Teleflex Incorporated and Invacare Corporation) are also presented in detail.

Global Nebulizer Market Insights & Forecasts with Potential Impact of COVID-19 (2020-2024) - ResearchAndMarkets.com

Retrieved on: 
Thursday, May 7, 2020

The "Global Nebulizer (Jet, Mesh, Ultrasonic) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Nebulizer (Jet, Mesh, Ultrasonic) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.
  • The nebulizer market is expected to reach US$1.44 billion in 2024, recording a CAGR of 4.02%, during 2020-2024.
  • The global nebulizer market is fragmented into the jet nebulizer, mesh nebulizer and ultrasonic nebulizer.
  • The report provides a comprehensive analysis of the global nebulizer (Jet, Mesh & Ultrasonic) market.

InventHelp Inventor Develops Easy On Deodorant (IPL-681)

Retrieved on: 
Thursday, April 30, 2020

PITTSBURGH, April 30, 2020 /PRNewswire/ -- "I suffer with rheumatoid arthritis and can't use spray deodorants," said an inventor from Danville, Illinois.

Key Points: 
  • PITTSBURGH, April 30, 2020 /PRNewswire/ -- "I suffer with rheumatoid arthritis and can't use spray deodorants," said an inventor from Danville, Illinois.
  • "This inspired me to develop a better method of packaging deodorant that could easily be dispensed."
  • The original design was submitted to the Indianapolis sales office of InventHelp.
  • 18-IPL-681, InventHelp, 217 Ninth Street, Pittsburgh, PA 15222, or call (412) 288-1300 ext.